|
|||||
A group of well-known philanthropists is backing a new research program to find simple tests that reveal early indicators of Alzheimer’s disease in a person’s molecular make-up. . . . → Read More: Gates, Lauder Backing Early Alzheimer’s Biomarker Tests 
A company using genomic databases and artificial intelligence to discover new therapies for neurodegenerative diseases is raising $32 million in its first venture funding round. . . . → Read More: A.I. Drug Discovery Company Gains $32M in Early Funds 
A life science and health care investment company in the U.K. today revealed its 12th venture capital fund for start-up and current enterprises in the U.S. and Europe. . . . → Read More: New $315 Million Life Sciences Venture Fund Unveiled 
Our friends at CB Insights put together a chart showing Amazon’s largest acquisitions in dollar value, this weekend’s infographic. . . . → Read More: Infographic – Amazon’s Largest Acquisitions 
A laboratory for producing new types of biomaterials is scheduled to open next year on the University of Illinois campus in Urbana. . . . → Read More: University Tissue, Cell Fabrication Lab Set to Open  Comments are closed  Finance  biomedical, engineering, grant, life sciences, manufacturing, materials science, medical device, physical sciences, university 
A biotechnology company developing regenerative therapies for neurological disorders is receiving a Small Business Innovation Research grant to advance an experimental treatment for spinal cord injury. . . . → Read More: NIH Grant Funds New Spinal Cord Injury Treatment 
A company spun-off from a University at Buffalo biochemistry lab is the recipient of a small business grant to design a once-a-week drug for people with type 2 diabetes to control their blood sugar and weight. . . . → Read More: Univ. Spin-Off Developing Long-Lasting Diabetes Drug One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, entrepreneurs, grant, life sciences, NIH, pharmaceuticals, physical sciences, preclinical, university 
A three year-old company developing treatments for cancer with engineered T-cells from the immune system raised $150 million in its initial public offering of common stock. . . . → Read More: Cancer T-Cell Start-Up Gains $150 Million in IPO Comments are closed Finance biomedical, cancer, clinical trials, entrepreneurs, equity, Europe, investment, IPO, life sciences, pharmaceuticals, U.K., university 
A biotechnology company is receiving a grant from National Institute of Neurological Disorders and Stroke to advance its experimental treatments for amyotrophic lateral sclerosis, or ALS. . . . → Read More: $3.4M NIH Grant Funding New ALS Treatments Comments are closed Finance biomedical, biotechnology, entrepreneurs, equity, grant, investment, life sciences, NIH, pharmaceuticals, preclinical, university 
A new initiative in Europe is investigating the connection between a person’s molecular composition and autism, particularly when other disorders complicate that individual’s condition. . . . → Read More: 115M Euro Grant for Precision Medicine, Trials in Autism One comment - (Comments are closed) Finance biomedical, clinical trials, Europe, grant, life sciences, pharmaceuticals, U.K., university |
One Blood Test Fits All Diseases A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
||||
|
Copyright © 2018 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
